Osaic Holdings’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $341K | Buy |
1,095
+360
| +49% | +$112K | ﹤0.01% | 3122 |
|
|
2025
Q1 | $243K | Sell |
735
-1,889
| -72% | -$626K | ﹤0.01% | 3472 |
|
|
2024
Q4 | $810K | Buy |
2,624
+470
| +22% | +$145K | ﹤0.01% | 2372 |
|
|
2024
Q3 | $457K | Buy |
2,154
+736
| +52% | +$156K | ﹤0.01% | 2956 |
|
|
2024
Q2 | $397K | Buy |
1,418
+230
| +19% | +$64.4K | ﹤0.01% | 2960 |
|
|
2024
Q1 | $317K | Sell |
1,188
-93
| -7% | -$24.8K | ﹤0.01% | 3295 |
|
|
2023
Q4 | $296K | Sell |
1,281
-195
| -13% | -$45.1K | ﹤0.01% | 3615 |
|
|
2023
Q3 | $216K | Buy |
1,476
+1,143
| +343% | +$167K | ﹤0.01% | 3937 |
|
|
2023
Q2 | $76.9K | Buy |
333
+77
| +30% | +$17.8K | ﹤0.01% | 4644 |
|
|
2023
Q1 | $62K | Sell |
256
-256
| -50% | -$62K | ﹤0.01% | 4801 |
|
|
2022
Q4 | $149K | Sell |
512
-465
| -48% | -$135K | ﹤0.01% | 4108 |
|
|
2022
Q3 | $64K | Sell |
977
-11
| -1% | -$721 | ﹤0.01% | 4706 |
|
|
2022
Q2 | $71K | Sell |
988
-50
| -5% | -$3.59K | ﹤0.01% | 4675 |
|
|
2022
Q1 | $102K | Buy |
1,038
+103
| +11% | +$10.1K | ﹤0.01% | 4581 |
|
|
2021
Q4 | $78K | Buy |
935
+69
| +8% | +$5.76K | ﹤0.01% | 4786 |
|
|
2021
Q3 | $70K | Buy |
866
+560
| +183% | +$45.3K | ﹤0.01% | 4834 |
|
|
2021
Q2 | $30K | Buy |
306
+45
| +17% | +$4.41K | ﹤0.01% | 5391 |
|
|
2021
Q1 | $30K | Sell |
261
-63
| -19% | -$7.24K | ﹤0.01% | 5208 |
|
|
2020
Q4 | $36K | Buy |
324
+186
| +135% | +$20.7K | ﹤0.01% | 4760 |
|
|
2020
Q3 | $16K | Buy |
138
+38
| +38% | +$4.41K | ﹤0.01% | 5010 |
|
|
2020
Q2 | $11K | Sell |
100
-423
| -81% | -$46.5K | ﹤0.01% | 5102 |
|
|
2020
Q1 | $35K | Buy |
+523
| New | +$35K | ﹤0.01% | 4232 |
|